OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetes Care (2018) Vol. 41, Iss. 12, pp. 2669-2701
Open Access | Times Cited: 3144
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetes Care (2018) Vol. 41, Iss. 12, pp. 2669-2701
Open Access | Times Cited: 3144
Showing 1-25 of 3144 citing articles:
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Dawn Kleindorfer, Amytis Towfighi, Seemant Chaturvedi, et al.
Stroke (2021) Vol. 52, Iss. 7
Open Access | Times Cited: 1994
Dawn Kleindorfer, Amytis Towfighi, Seemant Chaturvedi, et al.
Stroke (2021) Vol. 52, Iss. 7
Open Access | Times Cited: 1994
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 9, pp. 841-851
Open Access | Times Cited: 1425
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 9, pp. 841-851
Open Access | Times Cited: 1425
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetologia (2018) Vol. 61, Iss. 12, pp. 2461-2498
Open Access | Times Cited: 1344
Melanie J. Davies, David A. D’Alessio, Judith Fradkin, et al.
Diabetologia (2018) Vol. 61, Iss. 12, pp. 2461-2498
Open Access | Times Cited: 1344
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 10, pp. 776-785
Open Access | Times Cited: 1283
Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 10, pp. 776-785
Open Access | Times Cited: 1283
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Juan P. Frías, Melanie J. Davies, Julio Rosenstock, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 6, pp. 503-515
Open Access | Times Cited: 1095
Juan P. Frías, Melanie J. Davies, Julio Rosenstock, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 6, pp. 503-515
Open Access | Times Cited: 1095
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse, Deborah J. Wexler, Απόστολος Τσάπας, et al.
Diabetes Care (2019) Vol. 43, Iss. 2, pp. 487-493
Open Access | Times Cited: 1050
John B. Buse, Deborah J. Wexler, Απόστολος Τσάπας, et al.
Diabetes Care (2019) Vol. 43, Iss. 2, pp. 487-493
Open Access | Times Cited: 1050
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
Michael A. Nauck, Daniel R. Quast, Jakob Wefers, et al.
Molecular Metabolism (2020) Vol. 46, pp. 101102-101102
Open Access | Times Cited: 962
Michael A. Nauck, Daniel R. Quast, Jakob Wefers, et al.
Molecular Metabolism (2020) Vol. 46, pp. 101102-101102
Open Access | Times Cited: 962
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Ian H. de Boer, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2020) Vol. 98, Iss. 4, pp. S1-S115
Open Access | Times Cited: 955
Ian H. de Boer, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2020) Vol. 98, Iss. 4, pp. S1-S115
Open Access | Times Cited: 955
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 653-662
Open Access | Times Cited: 915
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 653-662
Open Access | Times Cited: 915
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S111-S124
Open Access | Times Cited: 890
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S111-S124
Open Access | Times Cited: 890
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
Darren K. McGuire, Weichung Shih, Francesco Cosentino, et al.
JAMA Cardiology (2020) Vol. 6, Iss. 2, pp. 148-148
Open Access | Times Cited: 880
Darren K. McGuire, Weichung Shih, Francesco Cosentino, et al.
JAMA Cardiology (2020) Vol. 6, Iss. 2, pp. 148-148
Open Access | Times Cited: 880
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S98-S110
Open Access | Times Cited: 865
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S98-S110
Open Access | Times Cited: 865
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E. J. Lean, W. S. Leslie, Alison C. Barnes, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 5, pp. 344-355
Open Access | Times Cited: 756
Michael E. J. Lean, W. S. Leslie, Alison C. Barnes, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 5, pp. 344-355
Open Access | Times Cited: 756
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Melanie J. Davies, Louise Færch, Ole K. Jeppesen, et al.
The Lancet (2021) Vol. 397, Iss. 10278, pp. 971-984
Closed Access | Times Cited: 751
Melanie J. Davies, Louise Færch, Ole K. Jeppesen, et al.
The Lancet (2021) Vol. 397, Iss. 10278, pp. 971-984
Closed Access | Times Cited: 751
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S73-S84
Open Access | Times Cited: 740
Diabetes Care (2020) Vol. 44, Iss. Supplement_1, pp. S73-S84
Open Access | Times Cited: 740
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Peter Rossing, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. S1-S127
Open Access | Times Cited: 702
Peter Rossing, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. S1-S127
Open Access | Times Cited: 702
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S90-S102
Open Access | Times Cited: 688
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S90-S102
Open Access | Times Cited: 688
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S66-S76
Open Access | Times Cited: 686
Diabetes Care (2019) Vol. 43, Iss. Supplement_1, pp. S66-S76
Open Access | Times Cited: 686
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, et al.
Circulation (2019) Vol. 139, Iss. 17, pp. 2022-2031
Closed Access | Times Cited: 667
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, et al.
Circulation (2019) Vol. 139, Iss. 17, pp. 2022-2031
Closed Access | Times Cited: 667
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S140-S157
Open Access | Times Cited: 663
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S140-S157
Open Access | Times Cited: 663
5. Lifestyle Management:Standards of Medical Care in Diabetes—2019
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S46-S60
Closed Access | Times Cited: 623
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S46-S60
Closed Access | Times Cited: 623
6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S61-S70
Open Access | Times Cited: 608
Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S61-S70
Open Access | Times Cited: 608
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S83-S96
Open Access | Times Cited: 602
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S83-S96
Open Access | Times Cited: 602
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martín Cowie, Miles Fisher
Nature Reviews Cardiology (2020) Vol. 17, Iss. 12, pp. 761-772
Closed Access | Times Cited: 572
Martín Cowie, Miles Fisher
Nature Reviews Cardiology (2020) Vol. 17, Iss. 12, pp. 761-772
Closed Access | Times Cited: 572
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 550
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 550
